Anti-Granzyme B antibody [EPR22645-244]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal Granzyme B antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Mouse samples. Cited in 3 publications.
View Alternative Names
Ctla-1, Ctla1, Gzmb, CTLA-1, Cytotoxic cell protease 1, Fragmentin-2, CCP1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Granzyme B antibody [EPR22645-244] (AB255599)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed, 0.1% Tween-20 permeabilized Mouse splenocyte (treated with 2.5ug/ml Concanavalin A for 72h) cells labelling Granzyme B with ab255599 at 1/800 dilution (Right) compared with a Rabbit monoclonal IgG (ab172730) isotype control (Left).
Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.
Cells were surface stained with anti-CD8 alpha conjugated to Alexa Fluor® 647.Then fixed with 2% PFA for 10min and intracellularly stained with rabbit IgG (Left) or ab255599 (Right).
- WB
Unknown
Western blot - Anti-Granzyme B antibody [EPR22645-244] (AB255599)
The expression of Granzyme B is elevated in stimulated splenocytes. Granzyme B forms a complex with its protease inhibitor. The molecular weight observed is consistent with what has been described in the literature (PMID : 8663264, PMID : 17116752, PMID : 21919028, PMID : 9774654).
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Granzyme B antibody [EPR22645-244] (ab255599) at 1/1000 dilution
Lane 1:
Untreated mouse splenocyte lysate at 20 µg
Lane 2:
Mouse splenocyte (treated with 2.5μg/ml Concanavalin for 72 hours ) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 28 kDa
Observed band size: 27 kDa,65 kDa
false
Exposure time: 3s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Granzyme B participates prominently in the immune response by activating caspases particularly caspase-3 which promotes the breakdown of cellular components necessary for apoptosis. Granzyme B does not function in isolation but acts in concert with other immune system factors such as perforin to effectively induce cell death. Perforin creates pores in the target cell membrane allowing granzyme B to enter and instigate the apoptosis sequence. The enzyme also contributes to the processing of cytokines which enhances the immune response further.
Pathways
Studies have determined that granzyme B is critical in the apoptosis pathway particularly in the granule exocytosis pathway. It closely interacts with proteins such as perforin and other granzymes to mediate apoptosis in target cells. Granzyme B also plays a role in the inflammatory response and can influence pathways associated with cytotoxic T cell signaling. Its pathway interactions ensure effective elimination of damaged or infected cells maintaining tissue homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:112988 PubMed41054545
2025
Applications
Unspecified application
Species
Unspecified reactive species
Histology and histopathology 40:1061-1071 PubMed39410869
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell genomics 4:100659 PubMed39317187
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com